[P29] Poster Session 29　Lung Cancer/Thoracic Cancer（ICI efficacy 1）

[P29-2] Significance of maintenance therapy following induction immunochemotherapy for advanced NSCLC patients

^○Ryota Nakamura¹, Tadaaki Yamada¹, Kenji Morimoto¹, Akira Nakao², Yasuhiro Goto³, Takayuki Takeda⁴, Chieko Takumi⁵, Yusuke Chihara⁶, Takahiro Yamada⁷, Osamu Hiranuma⁸, Koichi Takayama¹ (1.Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 2.Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, 3.Department of Respiratory Medicine, Fujita Health University School of Medicine, 4.Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, 5.Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, 6.Department of Respiratory Medicine, Uji-Tokushukai Medical Center, 7.Department of Pulmonary Medicine, Matsushita Memorial Hospital, 8.Department of Pulmonary Medicine, Otsu City Hospital)